Influence of nonalcoholic fatty liver disease on inflammatory bowel disease hospitalizations in the United States

BACKGROUND: The reported prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with inflammatory bowel disease (IBD) is 32%. We assessed the influence of NAFLD on IBD hospitalizations in the United States (US). METHODS: We utilized the National Inpatient Sample database, from 2016-2019,...

Descripción completa

Detalles Bibliográficos
Autores principales: Soni, Aakriti, Yekula, Anuroop, Dahiya, Dushyant Singh, Sundararajan, Ramaswamy, Dutta, Priyata, Singh, Yuvaraj, Cheng, Chin-I, Abraham, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662065/
https://www.ncbi.nlm.nih.gov/pubmed/38023970
http://dx.doi.org/10.20524/aog.2023.0839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662065/
https://www.ncbi.nlm.nih.gov/pubmed/38023970
http://dx.doi.org/10.20524/aog.2023.0839

Ejemplares similares